Targeted deletion of the lipopolysaccharide (LPS)-binding protein gene leads to profound suppression of LPS responses ex vivo, whereas in vivo responses remain intact - Wurfel, MM; Monks, BG; Ingalls, RR (J Exp Med, 1997)
et al.